Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Koji Mugishima"'
Autor:
Kohsuke Terada, Tomohiro Yan, Koji Mugishima, Sayuri Kawasaki, Fumiaki Itagaki, Takehisa Yamada, Yukinao Sakai
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Abstract Introduction Peritonitis is a crucial complication that leads to hospitalization or even death in patients who are undergoing peritoneal dialysis (PD). The incidence of PD-related peritonitis associated with nontuberculous mycobacteria has i
Externí odkaz:
https://doaj.org/article/daf4935991544992b39015e45ad06387
Autor:
Kohsuke Terada, Yukinao Sakai, Yuichiro Sumi, Koji Mugishima, Sayuri Kawasaki, Fumiaki Itagaki, Takehisa Yamada, Shuichi Tsuruoka
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Heart failure is a significant cause of death and hospitalization in dialysis patients. Controlling the volume status in PD, especially, is difficult, and transferring the PD patients to hemodialysis results mainly from ultrafiltr
Externí odkaz:
https://doaj.org/article/f3d5d30e8f1a45c1a25612dc07c4c7e1
Autor:
Yukinao Sakai, Saori Sakai, Koji Mugishima, Anna Katayama, Yuichiro Sumi, Yusuke Otsuka, Tomoyuki Otsuka, Shuichi Tsuruoka
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-8 (2017)
Abstract Background There are very few oral antidiabetic drugs recommended for patients on dialysis. Saxagliptin is known for its potent effect and long duration of action. In this study, we compared the efficacy of Saxagliptin with Mitiglinid for di
Externí odkaz:
https://doaj.org/article/d31f32e84a554e7f8566643bfe512936
Autor:
Kohsuke Terada, Takehisa Yamada, Koji Mugishima, Sayuri Kawasaki, Yukinao Sakai, Fumiaki Itagaki
Publikováno v:
International Journal of Nephrology and Renovascular Disease. 13:157-162
Low-density lipoprotein apheresis (LDL-A) has been developed as a therapy for familial hypercholesterolemia, but LDL-A has also been used as a general treatment for drug-resistant nephrotic syndrome (NS) due to focal segmental glomerulosclerosis (FSG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714cb42754de586b5d68d6b52e723da0
https://doi.org/10.2147/ijnrd.s248610
https://doi.org/10.2147/ijnrd.s248610
Autor:
Yukinao Sakai, Shuichi Tsuruoka, Koji Mugishima, Fumiaki Itagaki, Yuichiro Sumi, Kohsuke Terada, Sayuri Kawasaki, Takehisa Yamada
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-8 (2019)
Background Heart failure is a significant cause of death and hospitalization in dialysis patients. Controlling the volume status in PD, especially, is difficult, and transferring the PD patients to hemodialysis results mainly from ultrafiltration fai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd5db0409daa34d8cb56e904fc9d990
http://link.springer.com/article/10.1186/s41100-019-0231-x
http://link.springer.com/article/10.1186/s41100-019-0231-x
Autor:
Takehisa Yamada1 t-yamada@nms.ac.jp, Koji Mugishima1, Seiichiro Higo1, Yukie Yoshida1, Fumiaki Itagaki1, Shizuka Yui1, Tetsuya Kashiwagi1, Yoko Endo2, Akira Shimizu2, Shuichi Tsuruoka3
Publikováno v:
Journal of Nippon Medical School. 2018, Vol. 85 Issue 2, p138-144. 7p.
Autor:
Yukinao Sakai, Koji Mugishima, Takehisa Yamada, Kohsuke Terada, Fumiaki Itagaki, Sayuri Kawasaki, Tomohiro Yan
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Introduction Peritonitis is a crucial complication that leads to hospitalization or even death in patients who are undergoing peritoneal dialysis (PD). The incidence of PD-related peritonitis associated with nontuberculous mycobacteria has increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f36a23ff44343a5188af39d9f0890bc
https://doi.org/10.1186/s41100-020-00272-1
https://doi.org/10.1186/s41100-020-00272-1
Autor:
Koji Mugishima, Yuichiro Sumi, Tomoyuki Otsuka, Yukinao Sakai, Anna Katayama, Yusuke Otsuka, Shuichi Tsuruoka, Saori Sakai
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-8 (2017)
Background There are very few oral antidiabetic drugs recommended for patients on dialysis. Saxagliptin is known for its potent effect and long duration of action. In this study, we compared the efficacy of Saxagliptin with Mitiglinid for diabetes co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df94e243c320926c9b1bd0caae7885f6
http://link.springer.com/article/10.1186/s41100-017-0098-7
http://link.springer.com/article/10.1186/s41100-017-0098-7
Autor:
Anna Suzuki, Yukinao Sakai, Yusuke Otsuka, Yuichiro Sumi, Tomoyuki Otsuka, Koji Mugishima, Shuichi Tsuruoka
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 85(2)
Introduction Various innovations for preventing complications and improving a patient's quality of life have been implemented for peritoneal dialysis (PD), which was established in Japan approximately 35 years ago and introduced at our hospital in 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1224e4f1f540e75ffe659fc76b3d6d6c
https://pubmed.ncbi.nlm.nih.gov/29731493
https://pubmed.ncbi.nlm.nih.gov/29731493
Autor:
Shuichi Tsuruoka, Shizuka Yui, Akira Shimizu, Takehisa Yamada, Tetsuya Kashiwagi, Fumiaki Itagaki, Yoko Endo, Seiichiro Higo, Koji Mugishima, Yukie Yoshida
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 85(2)
We report here a case of systemic lupus erythematosus (SLE) with pulmonary hemorrhage and anti-glomerular basement membrane (anti-GBM) antibodies. A 42-year-old woman was admitted to our hospital with complaints of exanthema, arthralgia, shortness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c96dabc9aa6dcc5ab57ec345ea665af
https://pubmed.ncbi.nlm.nih.gov/29731498
https://pubmed.ncbi.nlm.nih.gov/29731498